These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 23356990)

  • 1. Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys.
    Yamagami Y; Mashiba T; Iwata K; Tanaka M; Nozaki K; Yamamoto T
    Bone; 2013 May; 54(1):1-7. PubMed ID: 23356990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of suppressed bone remodeling by minodronic acid and alendronate on bone mass, microdamage accumulation, collagen crosslinks and bone mechanical properties in the lumbar vertebra of ovariectomized cynomolgus monkeys.
    Mashiba T; Saito M; Yamagami Y; Tanaka M; Iwata K; Yamamoto T
    Bone; 2017 Apr; 97():184-191. PubMed ID: 28082077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of crystallographic orientation of biological apatite in vertebral cortical bone in ovariectomized cynomolgus monkeys treated with minodronic acid and alendronate.
    Tanaka M; Matsugaki A; Ishimoto T; Nakano T
    J Bone Miner Metab; 2016 Mar; 34(2):234-41. PubMed ID: 25837430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minodronic acid ameliorates vertebral bone strength by increasing bone mineral density in 9-month treatment of ovariectomized cynomolgus monkeys.
    Tanaka M; Mori H; Kawabata K; Mashiba T
    Bone; 2016 Jul; 88():157-164. PubMed ID: 27155564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys.
    Mori H; Tanaka M; Kayasuga R; Masuda T; Ochi Y; Yamada H; Kishikawa K; Ito M; Nakamura T
    Bone; 2008 Nov; 43(5):840-8. PubMed ID: 18718565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.
    Allen MR; Iwata K; Phipps R; Burr DB
    Bone; 2006 Oct; 39(4):872-9. PubMed ID: 16765660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone remodeling at the iliac crest can predict the changes in remodeling dynamics, microdamage accumulation, and mechanical properties in the lumbar vertebrae of dogs.
    Mashiba T; Hui S; Turner CH; Mori S; Johnston CC; Burr DB
    Calcif Tissue Int; 2005 Sep; 77(3):180-5. PubMed ID: 16265598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib.
    Komatsubara S; Mori S; Mashiba T; Li J; Nonaka K; Kaji Y; Akiyama T; Miyamoto K; Cao Y; Kawanishi J; Norimatsu H
    J Bone Miner Res; 2004 Jun; 19(6):999-1005. PubMed ID: 15125797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microdamage accumulation in the monkey vertebra does not occur when bone turnover is suppressed by 50% or less with estrogen or raloxifene.
    Li J; Sato M; Jerome C; Turner CH; Fan Z; Burr DB
    J Bone Miner Metab; 2005; 23 Suppl():48-54. PubMed ID: 15984414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of combined teriparatide and monthly minodronic acid therapy on cancellous bone mass in ovariectomized rats: a bone histomorphometry study.
    Iwamoto J; Seki A; Sato Y
    Bone; 2014 Jul; 64():88-94. PubMed ID: 24727162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with eldecalcitol positively affects mineralization, microdamage, and collagen crosslinks in primate bone.
    Saito M; Grynpas MD; Burr DB; Allen MR; Smith SY; Doyle N; Amizuka N; Hasegawa T; Kida Y; Marumo K; Saito H
    Bone; 2015 Apr; 73():8-15. PubMed ID: 25482210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles.
    Mashiba T; Turner CH; Hirano T; Forwood MR; Johnston CC; Burr DB
    Bone; 2001 May; 28(5):524-31. PubMed ID: 11344052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.
    Mashiba T; Hirano T; Turner CH; Forwood MR; Johnston CC; Burr DB
    J Bone Miner Res; 2000 Apr; 15(4):613-20. PubMed ID: 10780852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
    Gasser JA; Ingold P; Venturiere A; Shen V; Green JR
    J Bone Miner Res; 2008 Apr; 23(4):544-51. PubMed ID: 18072878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.
    Balena R; Toolan BC; Shea M; Markatos A; Myers ER; Lee SC; Opas EE; Seedor JG; Klein H; Frankenfield D
    J Clin Invest; 1993 Dec; 92(6):2577-86. PubMed ID: 8254015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 4-amino-1-hydroxybutylidene bisphosphonate on bone biomechanics in rats.
    Toolan BC; Shea M; Myers ER; Borchers RE; Seedor JG; Quartuccio H; Rodan G; Hayes WC
    J Bone Miner Res; 1992 Dec; 7(12):1399-406. PubMed ID: 1481726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination treatment with eldecalcitol (ED-71) and raloxifene improves bone mechanical strength by suppressing bone turnover and increasing bone mineral density in ovariectomized rats.
    Takeda S; Sakai S; Shiraishi A; Koike N; Mihara M; Endo K
    Bone; 2013 Mar; 53(1):167-73. PubMed ID: 23232307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
    Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
    J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.